Publications by authors named "Bertrand Nougarede"
Comparing ethanol lock therapy versus vancomycin lock in a salvation strategy for totally implantable vascular access device infections due to coagulase-negative staphylococci (the ETHALOCK study): a prospective double-blind randomized clinical trial.
Olivier Lesens Emmanuel Forestier Elisabeth Botelho-Nevers Patricia Pavese Gary David Bertrand Nougarede
Eur J Clin Microbiol Infect Dis
February 2024
Article Synopsis
- This study aimed to assess the effectiveness and safety of ethanol lock therapy (ELT) versus vancomycin lock therapy (VLT) for treating infections in totally implantable venous access devices (TIVAD) caused by coagulase-negative staphylococci.
- Results showed a treatment success rate of 58.1% for the ELT group and 46.7% for the VLT group, with no significant difference in failure rates between the two therapies.
- The study concluded that both therapies had high treatment failure rates, and emphasizes that removing the TIVAD device is crucial to avoid complications, except in rare cases.
Background: It has recently been suggested that propofol exerts a protective effect on the occurrence of persistent pain after breast cancer surgery. We analysed data from a subcohort taken from a multicentre study to validate this information.
Objective: The objective of this article is to study the role of the agent used for maintenance of general anaesthesia on the occurrence of persistent pain, with adjustment for multiple pre and peri-operative variables using the generalised linear model.